Roundtable Discussion: Platelet Function Testing - Efficacy and Safety of Antiplatelet Agents

Published: 09 July 2015

Views:
364
Likes:
7

Views:
364
Likes:
7
Share:

Now Playing
Part 1
SESSION 1: THE CLINICAL VALUE OF PLATELET RE-ACTIVITY TESTING – AN INTRODUCTION
Jeff Dahlen

Up Next

36m 20s

Part 2 SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES
Robert F Storey, Guillaume Taylor, Jeff Dahlen

26m 44s

Part 3 SESSION 3: PLATELET REACTIVITY TESTING – TREATMENT OPTIONS FOR HIGH-RISK PCI PATIENTS
Robert F Storey, Jean-Philippe Collet, Antonio Colombo, Jeff Dahlen

29m 2s

Part 4 SESSION 4: A REVIEW OF THE PROCEDURES IN PERIPHERAL INTERVENTION THAT REQUIRE ANTIPLATELET THERAPY
Robert F Storey, Stavros Spiliopoulos, Jeff Dahlen

42m 39s

Part 5 SESSION 5: BALANCING THE EFFICIENCY AND SAFETY OF ANTIPLATELET AGENTS – A CROSS-THERAPY DISCUSSION
Robert F Storey, Antonio Colombo, Stavros Spiliopoulos, Guillaume Taylor, Jeff Dahlen

Average (ratings)

No ratings

Your rating

Overview

During ESC 2013 (NL), Radcliffe Cardiology, in association with the Interventional Cardiology Review journal, filmed a roundtable discussion entitled 'Balancing the Efficacy and Safety of Antiplatelet Agents'.

The discussion was moderated by Robert Storey, (Sheffield, UK). He was joined by expert group of physicians including Jean-Philippe Collet, (Paris, FR), Antonio Colombo, (Milan, IT), Jeff Daheln, (Accumetrics, US), Guillaume Taylor, (Paris, FR) and Stavros Spiliopoulos, (Rion, GR).

The meeting comprised of four multidisciplinary panel discussions on a range of topical issues related to antiplatelet therapy and platelet function testing

Target Audience

This educational activity is intended for an international audience, specifically:

Interventional Cardiologists
Interventional Radiologists
Aligned healthcare professional involved with antiplatelet therapy

Key Learning Objectives

Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:

Increase physician awareness of the multidisciplinary role of antiplatelet therapy
Increase understanding of the role of platelet function testing in high-risk PCI
Explain the emerging role of PFT in PAD
Assess the role of antiplatelets in neuro-endovascular procedures

More from this programme

Part 1

SESSION 1

1 session
SESSION 1: THE CLINICAL VALUE OF PLATELET RE-ACTIVITY TESTING – AN INTRODUCTION	Watch now

Part 2

SESSION 2

1 session
SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES	Watch now

Part 3

SESSION 3

1 session
SESSION 3: PLATELET REACTIVITY TESTING – TREATMENT OPTIONS FOR HIGH-RISK PCI PATIENTS	Watch now

Part 4

SESSION 4

1 session
SESSION 4: A REVIEW OF THE PROCEDURES IN PERIPHERAL INTERVENTION THAT REQUIRE ANTIPLATELET THERAPY	Watch now

Part 5

SESSION 5

1 session
SESSION 5: BALANCING THE EFFICIENCY AND SAFETY OF ANTIPLATELET AGENTS – A CROSS-THERAPY DISCUSSION	Watch now

Faculty Biographies

Jeff Dahlen

View full profile